Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Senior Scientist - Analytical Development and Quality Control

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours

Full-timeWaltham, MA, USA

About the Job

Requirements

A PhD with a minimum of 6 years, an MS with a minimum of 10 years, or a BS with a minimum of 12 years of experience in analytical development and quality control within the pharmaceutical or biotech industry.
Proven experience with peptides and/or small molecules in solid oral dosage forms.
Experience managing outsourced activities with Contract Development and Manufacturing Organizations (CDMOs).
Strong expertise in analytical techniques such as high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), mass spectrometry (MS), gas chromatography (GC), dissolution, and spectroscopic methods.
Knowledge of regulatory requirements from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), and International Council for Harmonisation (ICH) guidelines related to analytical development.
A degree in Analytical Chemistry, Chemistry, Pharmaceutical Sciences, or a related field at the PhD or MS level, or a BS degree with a commensurate amount of directly applicable industry experience.
Ability to work on-site in Waltham, Massachusetts 3–4 days per week.

Responsibilities

Participate in the assessment and selection of Contract Development and Manufacturing Organizations (CDMOs).
Oversee analytical activities conducted by CDMOs to ensure external partners fulfill technical needs and quality standards.
Perform detailed review and provide data integrity oversight of data generated at CDMOs.
Ensure appropriate methods are developed and implemented for drug substance and drug product based on identified critical quality attributes.
Provide oversight of phase-appropriate method validation activities in alignment with current regulatory requirements.
Oversee stability programs to support product retest, shelf-life, and expiration dating.
Contribute to the preparation of data summaries and reports, and review data for regulatory submissions, including INDs, NDAs, and IMPDs.
Ensure analytical methods and data meet regulatory requirements, generate data to justify specification limits, and assess trends in stability data.
Ensure all analytical activities comply with Good Manufacturing Practices (GMP), ICH guidelines, and other relevant regulations.
Participate in internal and external investigations of quality events, including deviations, corrective and preventive actions (CAPAs), and out-of-specification (OOS) results.
Work closely with Manufacturing and Quality Assurance teams to generate cGMP-compliant data during product development and manufacturing.
Provide technical guidance and support to internal teams and external partners.
Oversee the preparation and review of technical documents, including protocols, reports, and standard operating procedures (SOPs).
Ensure data integrity and traceability in all analytical documentation.

Desired Qualifications

Experience developing discriminatory dissolution methods to support late-phase process changes, scale-up, and comparability for solid oral dosage forms.
Experience developing small-molecule drug substance impurity control strategies, including qualification, fate-and-purge, and specification setting.

At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.

We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.

What You’ll Do:

The Senior Scientist, Analytical Development and Quality Control will support analytical development and quality control activities performed by our external partners for cGMP manufacturing, quality release, and stability. The Senior Scientist will work directly with technical counterparts at vendor sites to implement the required product controls and ensure the integrity of data generated by our external partners. This role will also provide critical support for regulatory filings and ensure compliance with global regulatory standards.

Required location: Waltham, MA (hub-based, onsite 3-4 days per week)

Responsibilities:

Participate in the assessment and selection of Contract Development and Manufacturing Organizations (CDMOs)
Oversee analytical activities conducted by these CDMOs to ensure external partners fulfill technical needs and quality standards
Perform detailed review and provide data integrity oversight of data generated at CDMOs
Ensure appropriate methods are developed and implemented for drug substance and drug product based on identified critical quality attributes
Provide oversight of phase-appropriate method validation activities in alignment with current regulatory requirements
Oversee stability programs to support product retest, shelf-life, and expiration dating
Contribute to the preparation of data summaries and reports, and data review of regulatory submissions (INDs, NDAs, IMPDs)
Ensure analytical methods and data meet regulatory requirements, generate data to justify specification limits, and assess trends in stability data
Ensure all analytical activities comply with GMP, ICH guidelines, and other relevant regulations
Participate in internal and external investigations of quality events (e.g., deviations, CAPAs, OOS, etc.)
Work closely with Manufacturing and Quality Assurance teams to generate cGMP compliant data during product development and manufacturing
Provide technical guidance and support to internal teams and external partners
Oversee the preparation and review of technical documents, including protocols, reports, and SOPs
Ensure data integrity and traceability in all analytical documentation

Required Qualifications:

D. with a minimum of 6 years, MS with a minimum of 10 years, or BS with a minimum of 12 years of experience in analytical development and quality control within the pharmaceutical or biotech industry
Proven experience with peptides and/or small molecules in solid oral dosage forms
Experience managing outsourced activities with CDMOs
Strong expertise in analytical techniques such as HPLC, UPLC, MS, GC, dissolution, and spectroscopic methods
Knowledge of regulatory requirements (FDA, EMA) and ICH guidelines related to analytical development
Proven effective communication and interpersonal skills
Ability to work effectively in a fast-paced, collaborative environment

Preferred Qualifications:

Experience with development of discriminatory dissolution methods to support late-phase process changes, scale-up, and comparability for solid oral dosage forms
Experience with developing small molecule drug substance impurity control strategies, including qualification, fate-and-purge, and specification setting

Education:

PhD. or MS degree in Analytical Chemistry, Chemistry, Pharmaceutical Sciences, or related field, or a BS degree with a commensurate amount of directly applicable industry experience

Salary Range

$143,000—$175,000 USD

For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.

EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:

Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.

E-Verify:

Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.

#LI-Hybrid

Salary Range 143000 - 175000 USD

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size: 51-200
Company stage: IPO
Headquarters: Waltham, MA
Founded: 2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs